Follow
Carlos Roberto de Mello Rieder
Carlos Roberto de Mello Rieder
Coordenador Ambulatório Distúrbios do Movimento HCPA, Professor Neurologia, UFCSPA
Verified email at hcpa.edu.br
Title
Cited by
Cited by
Year
Identification of blood microRNAs associated to Parkinsońs disease
R Margis, R Margis, CRM Rieder
Journal of biotechnology 152 (3), 96-101, 2011
3072011
DNAJC6 Mutations Associated With Early‐Onset Parkinson's Disease
S Olgiati, M Quadri, M Fang, JPMA Rood, JA Saute, HF Chien, ...
Annals of neurology 79 (2), 244-256, 2016
1862016
Iron and oxidative stress in Parkinson’s disease: an observational study of injury biomarkers
MS Medeiros, A Schumacher-Schuh, AM Cardoso, GV Bochi, ...
PloS one 11 (1), e0146129, 2016
1532016
Characterization of cognitive and motor performance during dual-tasking in healthy older adults and patients with Parkinson’s disease
LB Wild, DB de Lima, JB Balardin, L Rizzi, BL Giacobbo, HB Oliveira, ...
Journal of neurology 260, 580-589, 2013
1482013
Effects of Nordic walking training on functional parameters in Parkinson's disease: a randomized controlled clinical trial
EP Monteiro, LT Franzoni, DM Cubillos, A de Oliveira Fagundes, ...
Scandinavian journal of medicine & science in sports 27 (3), 351-358, 2017
1332017
LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study
M Quadri, W Mandemakers, MM Grochowska, R Masius, H Geut, ...
The Lancet Neurology 17 (7), 597-608, 2018
1212018
S100B and NSE serum levels in patients with Parkinson's disease
DV Schaf, ABL Tort, D Fricke, P Schestatsky, LVC Portela, DO Souza, ...
Parkinsonism & related disorders 11 (1), 39-43, 2005
1042005
DRD2 haplotype is associated with dyskinesia induced by levodopa therapy in Parkinson’s disease patients
M Rieck, AF Schumacher-Schuh, V Altmann, CLM Francisconi, ...
Pharmacogenomics 13 (15), 1701-1710, 2012
972012
Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson´ s disease
EF Dos Santos, ENB Busanello, A Miglioranza, Â Zanatta, AG Barchak, ...
Metabolic brain disease 24, 257-269, 2009
912009
Interleukin-6 serum levels in patients with Parkinson’s disease
KW Hofmann, AFS Schuh, J Saute, R Townsend, D Fricke, R Leke, ...
Neurochemical research 34, 1401-1404, 2009
902009
A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3)
C Kieling, CRM Rieder, ACF Silva, JAM Saute, CR Cecchin, TL Monte, ...
European journal of neurology 15 (4), 371-376, 2008
872008
A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm
CRM Rieder, P Schestatsky, MP Socal, TL Monte, D Fricke, J Costa, ...
Clinical neuropharmacology 30 (1), 39-42, 2007
812007
A randomized, phase 2 clinical trial of lithium carbonate in Machado‐Joseph disease
JAM Saute, RM de Castilhos, TL Monte, AF Schumacher‐Schuh, ...
Movement Disorders 29 (4), 568-573, 2014
792014
Depressive symptoms in Machado-Joseph disease (SCA3) patients and their relatives
CR Cecchin, AP Pires, CR Rieder, TL Monte, I Silveira, T Carvalho, ...
Public Health Genomics 10 (1), 19-26, 2006
732006
Quality of life in a Brazilian sample of patients with Parkinson's disease and their caregivers
P Schestatsky, VC Zanatto, R Margis, E Chachamovich, M Reche, ...
Brazilian Journal of Psychiatry 28, 209-211, 2006
712006
Hyperhidrosis in Parkinson's disease
P Schestatsky, J Valls‐Solé, JA Ehlers, CRM Rieder, I Gomes
Movement disorders 21 (10), 1744-1748, 2006
692006
Evaluation of sympathetic skin response in Parkinson's disease
P Schestatsky, JA Ehlers, CRM Rieder, I Gomes
Parkinsonism & related disorders 12 (8), 486-491, 2006
682006
Intrafamilial variability of Parkinson phenotype in SCAs: novel cases due to SCA2 and SCA3 expansions
MP Socal, VE Emmel, CRM Rieder, A Hilbig, ML Saraiva-Pereira, ...
Parkinsonism & related disorders 15 (5), 374-378, 2009
662009
The impact of dysphagia therapy on quality of life in patients with Parkinson's disease as measured by the swallowing quality of life questionnaire (SWALQOL)
A Ayres, GP Jotz, CRM Rieder, AFS Schuh, MR Olchik
International archives of otorhinolaryngology 20, 202-206, 2016
612016
Cytochrome P450 1B1 mRNA in the human central nervous system.
CR Rieder, DB Ramsden, AC Williams
Molecular Pathology 51 (3), 138, 1998
611998
The system can't perform the operation now. Try again later.
Articles 1–20